Quality Matters | U.S. Pharmacopeia Blog

// June 17, 2024

Biologics and biosimilars – the basics

Biologic medicines – “biologics” for short. You’ve probably seen commercials for some of them on TV. Maybe you or someone you know is even taking one. But what exactly are they? And what about “biosimilars” ? You might also be wondering whether they’re safe and effective.

USP Staff

Producing maternal health supplies in sub-Saharan Africa

Global Health

// March 13, 2024

Producing maternal health supplies in sub-Saharan Africa ...

Understanding the landscape to expand, strengthen, and diversify African-based manufacturing

Perrer Tosso, Ph.D. Safia Ahsan

Medicines

// November 28, 2023

FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards ...

This year has seen a flurry of activity by the U.S. Food and Drug Administration surrounding ophthalmic products.

Desmond Hunt Margareth Marques

Biologics

// June 17, 2024

Biologics and biosimilars – the basics

USP Staff

advancing pharmaceutical manufacturing in Africa

Global Health

// June 24, 2024

Advancing regional manufacturing in Africa: Four key takeaways from the 77th World He...

Expanding regional manufacturing in Africa relies on capable suppliers and a predictable demand. Following the World Health Assembly, we explore four ways to advance medicines manufacturing on the continent. Read the blog.

Emily Kaine, M.D. Allie Phillips

Supply Chain

// October 24, 2023

Why cancer medicines are and continue to be vulnerable to drug shortages...

Analysis leveraging USP’s Medicine Supply Map suggests many of the essential cancer medicines have inherently vulnerable supply chains and are at greater risk for shortage compared to other generic medicines.

Vimala Raghavendran Praewpaka Drucker

Featured Videos

View All Videos

Quality Medicines for Malaria

Global Health

// May 24, 2018

Quality Medicines for Malaria

Marie Lamy with Asia Pacific Leaders Malaria Alliance discusses how one country is tackling drug resistance in order to eradicate Malaria.

Poor quality medicines and drug resistance

Global Health

// May 24, 2018

Poor quality medicines and drug resistance

Harvard professor and physician Ashish Jha describes how poor quality medicines create the perfect opportunity for superbugs.

Quality medicines and sub-Saharan Africa

Global Health

// May 24, 2018

Quality medicines and sub-Saharan Africa

Global health advocate Mirfin Moundu talks about the dangers of poor quality medicines and how they are a threat to many Africans in treating infectious diseases and non-communicable diseases.

QMBlog Content

Discover More:

I am interested in:

and:

Supply Chain

// June 14, 2023

Good distribution practices require coordination, collaboration, and continuous quali...

When it comes to good distribution practices (GDPs) for medical products, patient safety is the highest priority, panelists affirmed during an April 26 session of the Asia-Pacific Economic Cooperation (APEC) forum’s

Luciana Shimizu Takara

Supply Chain

// June 13, 2023

Implementing regulatory reforms and investing in supply chain integrity for pandemic ...

While the U.S. and World Health Organization (WHO) have declared an end to the public health emergency, opportunities remain for regulatory reforms to bolster supplies of quality medicines and prepare for the next pandemic.

Anthony Lakavage, J.D.

Medicines

// June 12, 2023

Complex generics: The need and challenges

Generic medicines have benefited millions of Americans and saved trillions of dollars.

Prabhakar Gruddanti

Speakers at USP's Workshop on Nitrosamines Impurities

Medicines

// June 08, 2023

Insights from India: Q&A with USP nitrosamines expert...

The issue of addressing potential nitrosamine impurities in medicines has been the focus at events taking place around the globe in recent months and will continue to do so throughout 2023.

Mrunal Jaywant

Supply Chain

// June 06, 2023

Thinking differently about excipient quality to ensure medicines supply chain resilie...

The quality of excipients in medicines – which make up every part of a drug other than the active pharmaceutical ingredient (API) – is critical to a resilient medicines supply chain, panelists agreed at an April 25 session of the Asia-Pacific Economic Cooperation (

John Giannone

Supply Chain

// May 25, 2023

Impurities in the medicines supply chain: Global cooperation essential to safeguardin...

Continued global cooperation to strengthen supply chain resilience and assure medicines quality was a recurring theme at the Asia-Pacific Economic Cooperation (APEC) forum’s

Edwin Gump, PhD

Biologics and biosimilars – the basics

Producing maternal health supplies in sub-Saharan Africa ...

FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards ...

Biologics and biosimilars – the basics

Advancing regional manufacturing in Africa: Four key takeaways from the 77th World He...

Why cancer medicines are and continue to be vulnerable to drug shortages...

Featured Videos

Quality Medicines for Malaria

Poor quality medicines and drug resistance

Quality medicines and sub-Saharan Africa

Discover More:

Good distribution practices require coordination, collaboration, and continuous quali...

Implementing regulatory reforms and investing in supply chain integrity for pandemic ...

Complex generics: The need and challenges

Insights from India: Q&A with USP nitrosamines expert...

Thinking differently about excipient quality to ensure medicines supply chain resilie...

Impurities in the medicines supply chain: Global cooperation essential to safeguardin...

Get the latest from Quality Matters to your inbox

Tweets by @USPharmacopeia